SCHEMBL19145341

SCHEMBL19145341

CN1CCN(C(=O)C[C@H](CSc2ccccc2)NC(=O)OCc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
CASP1 P29466 1/20 0.45
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
CTRB1 P17538 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GPR55 Q9Y2T6 2/20 0.43
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA2 P00918 1/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SYK P43405 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19145112 0.91 MEN1 (0.42) ALDH1A1TP53CYP3A4CASP1MEN1
SCHEMBL10058359 0.89 FKBP1A (0.52) ALDH1A1CASP1ITGB3ITGA2BCTRB1
SCHEMBL25087898 0.89 FKBP1A (0.52) ALDH1A1CASP1ITGB3ITGA2BCTRB1
SCHEMBL19145283 0.86 ALDH1A1 (0.44) ALDH1A1ITGB3ITGA2BHPGDHSD17B10
SCHEMBL19145558 0.85 MEN1 (0.44) ALDH1A1CYP3A4CASP1CTRB1MEN1
SCHEMBL19145111 0.85 MEN1 (0.44) ALDH1A1CYP3A4CASP1CTRB1MEN1
SCHEMBL19145250 0.84 MEN1 (0.43) ALDH1A1CASP1CTRB1MEN1KMT2A
SCHEMBL19145314 0.84 MEN1 (0.43) ALDH1A1CASP1CTRB1MEN1KMT2A
SCHEMBL19145231 0.83 MEN1 (0.42) ALDH1A1CASP1ITGB3ITGA2BCTRB1
SCHEMBL19145431 0.83 MEN1 (0.42) ALDH1A1CASP1ITGB3ITGA2BCTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123616-A1 INHIBITING B-CELL LYMPHOMA 2 (BCL-2) AND RELATED PROTEINS MERRIMACK PHARMACEUTICALS, INC. (US) 2017-07-20 WO disclosed